Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TRIM44 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SEZ6L2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZBTB4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TESK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ST6GALNAC6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TBC1D22B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CCDC25 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CTNS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EZH1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPIL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
STAT5B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FBXW5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PFKL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NAA60 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARHGAP4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CBR3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EIF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HLA-C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBE2Z - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on